Bacterial coinfections during murine cutaneous leishmaniasis
Abstract
Details
- Title: Subtitle
- Bacterial coinfections during murine cutaneous leishmaniasis
- Creators
- Tiffany Yue-Fei Borbon
- Contributors
- Mary E Wilson (Advisor)Alexander R Horswill (Committee Member)Jon C Houtman (Committee Member)Timothy L Yahr (Committee Member)Weizhou Zhang (Committee Member)
- Resource Type
- Dissertation
- Degree Awarded
- Doctor of Philosophy (PhD), University of Iowa
- Degree in
- Microbiology
- Date degree season
- Spring 2020
- DOI
- 10.17077/etd.005291
- Publisher
- University of Iowa
- Number of pages
- xxi, 173 pages
- Copyright
- Copyright 2019 Tiffany Yue-Fei Borbon
- Language
- English
- Description illustrations
- color illustrations
- Description bibliographic
- Includes bibliographical references (pages 153-173).
- Public Abstract (ETD)
Cutaneous leishmaniasis is a vector-borne disease that affects over 12 million people worldwide, causing skin nodules that ulcerate and heal with disfiguring scars. It is caused by Leishmania species parasites, which are transmitted by sand fly bites. Most Leishmania infections are asymptomatic, and the factors that lead to symptomatic infection are not fully understood. When an infected sand fly takes a blood meal, bacteria can be inoculated into the skin with the parasite. Staphylococcus aureus is the most common bacterium in cutaneous leishmaniasis lesions. The effects of bacterial coinfection with Leishmania on the host immune system are largely unknown. We hypothesized that local bacteria influence the formation and severity of lesions that develop at the site of Leishmania infection. Using a mouse model, we found that S. aureus coinfection with L. major results in larger lesions than infection by either microbe alone. These exacerbated lesions were correlated with elevated S. aureus burdens early during coinfection, more neutrophils, and greater levels of two cytokines, IL-1β and IL-17A, which promote inflammation. Treatment with neutralizing antibodies against IL-1β further exacerbated coinfected lesions, but antibodies against IL-17A resulted in partially reduced lesion exacerbation during coinfection, suggesting that IL-17A contributes to exacerbated lesions in coinfection. We also used mice with an immunodeficiency and bacteria deficient in different virulence factors to better understand the mechanisms governing the outcomes of bacterial-leishmanial cutaneous coinfections. Our studies provide new insights into the effects of bacterial coinfection on the immune response to Leishmania and may contribute to novel approaches for reducing the severity of cutaneous leishmaniasis disease.
- Academic Unit
- Microbiology and Immunology
- Record Identifier
- 9983956197902771